SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ave " 38,639 found 🔀 AI-powered Shuffle
Twin City Entertainment collaboration to host the Carol Burrnett Show in West Monroe June 27th
WEST MONROE, La. (KTVE/KARD) — Residents in the West Monroe area will have the chance to enjoy a night of laughter later this week as a live stage production inspired by The Carol Burnett Sho…
Tunisia vs Netherlands Extended Highlights
Check out the full game highlights between Tunisia and Netherlands in the 2026 FIFA World Cup™. Announced by Darren Fletcher and Owen Hargreaves.
Japan vs Sweden Extended Highlights
Check out the full game highlights between Japan and Sweden in the 2026 FIFA World Cup™. Announced by Darren Fletcher and Owen Hargreaves.
It's Xbox's turn (again), as console prices keep going up
Microsoft announced a price hike for the Xbox Series consoles today, the third in little over a year. Effective August 1, the Xbox Series S, which launched in 2020 for $300, will cost $500 in the U.S. The Xbox Series X, which launched in 2020 at $500, will go for $800. This follows a round of PlayStation 5 price increases from Sony this spring, and a slow-motion increase for Nintendo’s Switch 2, which will kick in in the U.S. in September. (Mind you, there were also eight video game industry price hikes in six months of 2025). The chart up top shows the sudden ascent of console prices over the past year, a sudden surge in an already unusual hardware generation. Prices had been flat for years, now “up” is the new “flat.” Game console prices used to go down across the length of a console generation, but not this time around. Microsoft’s explanation for the new price hike today: We hoped another price increase would not be necessary, and we have spent the last several months working with suppliers on options. Unfortunately, console storage and memory prices have increased by more than 2.5x and we expect another doubling by the fall of 2027. The entire consumer electronics industry is struggling with the current components crisis, but the effects are particularly hard on consoles. Unlike phones, computers, speakers, and other consumer devices, consoles are typically not sold at a profit, but instead for less than they cost to make. This is an issue well beyond game consoles. Apple announced price hikes on its computers and tablets today as well. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: Brutal Bungie cuts Bungie laid off “most” of its Destiny development team and some developers who worked on Marathon, the newest game from the struggling Sony-owned studio. A WARN notice issued by Sony to Washington State, where Bungie is based, tallied cuts impacting 292 workers, effective next month. That’s strictly for Bungie/Sony jobs in Washington and wouldn’t account for any elsewhere. The video I clipped below shows the redacted list of Bungie cuts filed to Washington State officials. As you’ll see, I had to scroll for a while… In a note emailed to PlayStation workers and published online, PlayStation game studios chief Hermen Hulst offered the following explanation for these latest cuts at Bungie: This is painful news, especially for talented colleagues whose roles have been eliminated. This decision was made only after extensive discussion and careful consideration, and I want to provide some context on how we arrived here. Over the past several months, together with Bungie leadership, we reviewed the studio’s long-term direction, development priorities, resource needs, and role within our broader portfolio strategy. We explored multiple alternatives before concluding that a reduction was necessary to align the studio’s resources with its current priorities and long-term goals. In 2022, Sony bought Bungie for $3.7 billion. The studio’s marquee game, the multiplayer live service shooter Destiny 2 was losing popularity at the time. Its next game Marathon, released earlier this year, has been well-reviewed but had a slow start. Bungie is renowned for making great shooter games, and Destiny fans have mourned the wind-down of Destiny 2. They’ve also expressed bewilderment over reports that Destiny 3 is not, per Bloomberg, immediately in the cards.
Behavioral Healthcare Close to Home: SRMC Services Available in Sandoval County
Sandoval County spans more than 3,000 square miles with a population of 160,000 residents. As one of New Mexico’s fastest growing counties, it’s crucial the people who live there have access to high quality healthcare, including behavioral health...
JD Vance claims Diddy is 'not a Christian' after federal conviction
Sean "Diddy" Combs might have scored a reference in Vice President JD Vance's new book, but the politician is not eager to associate himself with the imprisoned music mogul.
Vance, an admirer of Richard Nixon, says Watergate would be 'a 12-hour news story' today
Vice President JD Vance says the Watergate scandal that brought down President Richard Nixon would have been a blip in today’s news cycle
Valve Deletes 4K 60FPS Claim From Steam Page After Reviews
Some have struggled to hit consistently high framerates on the new hardware
Kawhi Leonard Seeks Extension – But Not With Current Team
Kawhi Leonard has one year left on his current contract with the Los Angeles Clippers. He’s eligible to sign an extension this summer, and sounds like he’s willing to do get that done. The one caveat: The Clippers aren’t necessarily the team he wants to sign with. Leonard, who turns 35 on June 29, ...
New Orleans Pelicans Exercise Karlo Matkovic's Third-Year Option
The New Orleans Pelicans have exercised Karlo Matkovic's third-year option.
Golden State Valkyries employee named in Sports Business Journal's Forty under 40 list
The Golden State Valkyries have created a winning culture on and off the court. After making WNBA history last season becoming the first expansion team to reach the playoffs, the success is also extending throughout the organization.
Sephora CEO Guillaume Motte on Creating Demand and Scaling Desire
The beauty retailer’s chief executive spoke at day two of The Business of Beauty Global Forum about the strategies that have led to $5 billion in growth over the past three years.
ESPN believes Detroit Lions have best weapons in NFL
ESPN’s Bill Barnwell believes the Detroit Lions have better offensive weapons than any other NFL team in 2026.
Travelers Championship brings business boost and traffic headaches for Cromwell-area shops
As golfers compete at the Travelers Championship, nearby restaurants and shops in the Cromwell area are seeing the tournament’s impact on business, with some owners welcoming the crowds and others pointing to traffic challenges.
YouTube updates Shorts to make it even more like TikTok
Where have we seen these features before?
Shockwave Medical announces new studies evaluating carotid IVL platform
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
House Freedom Caucus pressures Senate to pass SAVE America Act
The House has passed the bill three times, but it is stalled in the Senate where it lacks the votes to pass
Earthquakes Have Often Shaken Latin American Politics
How governments respond to natural disasters can shape their political trajectories, an expert writes.
Officials offer lifeline to struggling French Quarter businesses
At least three businesses have closed due to ongoing construction.
Entrepreneurs pitched business ideas to Yahoo Finance
Yahoo Finance Executive Editor Brian Sozzi is on the hunt for the next big business breakthrough. Check out the absolute best pitches and standout moments from the innovators making waves at Cannes Lions.
This week in science: Exoplanetary salt clouds, ancient families and laughter's origin
Hosts from NPR's science podcast Short Wave talk about an exoplanet with pink, salty clouds, the surprising social structure of ancient human relatives and the origins of laughter.
This One Tax Move Could Save Your Company A Lot of Money
Still filing your tax returns as a "pass through" business? It may be time to change that.
These Churches Are Putting Family Before Politics
Close to 70 percent of Black children in America are born to unmarried parents. Nearly half live with a single mother. Both figures are significantly higher than the national average and reflect the steep decline in marriage among African Americans since the 1960s.
What to know about early warnings for earthquakes
Many countries have systems to alert people seconds before shaking begins in an earthquake. Experts say even a slight warning provides critical time for protection.
Three RWJBarnabas Health Hospitals Recognized Among Newsweek's Best Hospitals for Specialized Care for 2026
Robert Wood Johnson University Hospital (RWJUH), Cooperman Barnabas Medical Center (CBMC) and Robert Wood Johnson University Hospital Somerset (RWJUH Somerset), all RWJBarnabas Health facilities, have been recognized among Newsweek's America’s Best Hospitals for Specialized Care 2026.
If I were traveling, Anker is the only company I would trust with my life to keep my tech fully charged at all times — and 11 of its best items are on sale right now
Get these Anker products to keep your gear always charged!
Dolly Parton surprises fans at opening of her new travel stop amid ongoing health battle
Parton had to cancel her Las Vegas residency after announcing she was being treated for an undisclosed health issue.
Fulton County health officials notify Johns Creek High School community of possible tuberculosis exposure
Students and staff who may have had close contact with the individual will receive separate notifications and be offered free tuberculosis testing.
Steam Summer Sale 2026 arrives: 10 hot video game deals
Do you like Star Wars? We have good news.
Impact of European heat wave on transportation, businesses, tourism
A heat wave across Europe caused record-breaking temperatures, affecting businesses, infrastructure, and daily life.
'Supergirl' scribe teases her lost DC movie for Sasha Calle
'Supergirl' scribe Ana Nogueira says the original movie she wrote for Sasha Calle's Kara Zor-El 'could not have been more different' than the Milly Alcock-led film.
The Ole-Miss All-Transfer Team: Offense
Now that NIL and the transfer portal are in full swing, creating NCAA Free Agency, there has been enough time for us to be able to go back and look at who have been the most impactful transfer Rebs so far. There will be an 11 man offense and 11 man defense and maybe an […]
5 states targeting Medicaid behavioral health enrollment amid fraud concerns
At least five states have taken steps in 2026 to restrict new Medicaid behavioral health provider enrollments as stakeholders seek to curb fraud, waste and abuse while strengthening oversight of high-risk services. The developments come as the Trump administration aims to crack down on healthcare fraud. On June 25, the Justice Department charged 455 people, […]
Google Finance finally gets a mobile app as AI-powered overhaul leaves beta
It took 20 years, but the Finance app arrives just in time to be packed full of AI.
Dave Roberts Gives Blunt Assessment on Dalton Rushing Controversy
Dodgers catcher Dalton Rushing had a rough game on Wednesday, June 24th, behind the dish, getting into a disagreement with Shohei Ohtani.
Adidas’ NIL pipeline is producing NBA rookies who already know the business
Mikel Brown Jr. reached the NBA with a head start few rookies have. Long before being selected sixth overall by the Brooklyn Nets at Tuesday’s NBA Draft, the 20-year-old guard had been embedded in Adidas’ ecosystem through a name, image and likeness deal that began in high school. “By the time our athletes walk across […]
Dating Coach Urges All Men to Avoid 'Worst' Hobby for Single Guys
A professional dating coach isn't holding back on the "F" tier hobby for single men in the United States. Blaine Anderson, a former travel industry worker who built a successful dating coach business,...
Rubio’s spin on the Iran MOU sounds different from Trump and Vance
For more than a week, America’s top diplomat was conspicuously quiet about something that would have seemed very much in his wheelhouse: a nascent agreement with Iran. But now Secretary of State Marco Rubio is speaking.
Trump Keeps Undercutting Republicans’ Message, Squandering His Own Trifecta
Divisions between the president and his party on Capitol Hill have muddled Republicans’ midterm pitch to voters, and have crippled the G.O.P. at what should be the peak of its power.
Microsoft is raising Xbox prices yet again — this time by up to $150
Microsoft said memory and storage prices have increased by "more than 2.5x" and it expects "another doubling by the fall of 2027."
Trump’s politics of emergencies leaves GOP allies scrambling again
In upending plans to sign a bipartisan housing bill, the president illustrated one of his favored tactics: declaring a policy preference to be an emergency.
Major blow for MacBook Ultra: Apple said to cancel M6 Pro and M6 Max
The Apple MacBook Ultra will either be released with the older Apple M5 Max, or its launch will be significantly delayed. This is because Apple is said to have halted development of the Apple M6 Pro and M6 Max in order to focus on the M7 series instead, which is expected to offer significantly stronger AI performance.
Sean Hannity Explains Puffy Face in Health Update Amid Viewer Concern
Sean Hannity gave a health update after viewers expressed concern about his puffy face and raspy voice in recent Fox News telecasts.
Q&A: What does science say about plants as medicine?
Plants have always played an integral role in traditional medicine and healing practices, according to Kent Vrana, Elliot S. Vesell Professor of Pharmacology at Penn State College of Medicine…
Europe heatwave breaks records as UN agencies ramp up health warnings
As a record-breaking heatwave grips large parts of Europe, the World Meteorological Organization (WMO), national weather services and partners are mobilising heat-health action plans for millions of people facing dangerous temperatures.
Prime Day Smartphone Deals Are Live: Save Up to 44% on Samsung Foldables, Google Pixels, Motorolas, and More
These are the Amazon Prime Day smartphone deals actually worth buying, featuring editor-approved picks from Samsung, Google, Motorola, and more.
Star Fox Players Are Up To Debauchery With Its VTuber Avatars
Who could have foreseen this?
'Avengers: Endgame' rerelease confirms new title, footage, and end tag
'Avengers: Endgame' rerelease gets a new title and confirms fresh footage and a special end tag.
The 2026 Colorado Rockies my dad would have loved
Productive additions prove to be easy to cheer on
Ranking Big 12 recruiting classes via average commit distance
The Big 12 recruiting landscape continues to change as programs continue to shuffle throughout the conference. Texas Tech is pushing to sign the nation’s No. 1 class in the 2027 cycle and it firmly sits atop the league’s recruiting rankings. The Red Raiders are the only Big 12 team with a top-25 haul, per the […]
Democratic socialists cemented power in New York. Next, the rest of the country?
The wins would not have been possible without significant support from Black and Latino voters who favored them over establishment candidates.
Another look at carrots and eyesight; how to get more fiber; why mosquitoes bite some people and not others; plus other stories with Vanderbilt Health sources
AARP reporter Stacey Colino interviewed Milam Brantley, MD, Associate Professor of Ophthalmology and Visual Sciences, in 2020 for a story about whether eating carrots can improve vision. Sacramento Bee reporter Samantha Agate has now used Brantley’s comments in an AI-curated story created by content specialists on the same topic that has been picked up by MSN and others. Prevention magazine interviewed Heidi Silver, RD, PhD, Founding Director of the Vanderbilt Diet, Body Composition, and Human Metabolism Core, for a story about the importance of fiber and how people can get more of it in their diet. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Women’s Health (tick bites and alpha-gal syndrome); The Washington Post (tetanus); and Healthline (why mosquitoes prefer to bite some people and leave others alone). A visit to Monroe Carell Jr. Children’s Hospital at Vanderbilt by some Banana Ball baseball players was covered by The Tennessean and WZTV Fox 17 News, and The Tennessean’s story was also picked up by Yahoo! Sports. Clarksville Now published a story written by the Montgomery County Economic Development Team, whointerviewed Bradley Stancombe, MD, professor of Clinical Pediatrics, Vanderbilt Neonatology, about the new energy of Vanderbilt Clarksville Hospital and how the facility is recruiting physicians. Healio Allergy/Asthma group editorial director Richard Gawel interviewed Mark Rolfsen, MD, Clinical Fellow in the Division of Allergy, Pulmonary and Critical Care Medicine, for a story about his presentation at the American Thoracic Society meeting on metal health outcomes following ICU discharge. Nashville Scene reporter Hannah Herner interviewed James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a story about his efforts to prepare for the next pandemic by isolating antibodies that can neutralize dangerous viruses. Medscape reporter Kathleen Doheny interviewed Neesha Choma, Associate Chief of Staff of Vanderbilt University Hospital, for a story about how hospitals can reduce readmissions.
CMS projects national health spending grew to $5.7 trillion in 2025
National health spending is projected to have reached $5.7 trillion in 2025, up 7.3% from 2024, according to an analysis by the Centers for Medicare & Medicaid Services published yesterday by Health Affairs. It marks the third consecutive year of growth greater than 7%. CMS projects growth to continue in 2026 due to continued demand for high-cost retail prescription drugs, mostly from individuals with Medicare and private insurance.
An Update from PlayStation Studios
Below is an internal email from Hermen Hulst, CEO, Studio Business Group, Sony Interactive Entertainment distributed today to SIE employees. ********************************************************************************** Dear Team, Today I want to share a difficult update regarding Bungie. We have made the decision to reduce Bungie’s workforce, affecting a significant number of employees, including most of the Destiny team and some Marathon team members. There are also reductions across SIE teams that support […]
York, Community Unite for Hands-On Environmental Science Journey
A group of students, faculty, and Southeast Queens residents recently traveled from the York College campus to the waterfront campus of Kingsborough Community College (KCC) in the Manhattan Beach neighborhood of Brooklyn to set sail in the Research Vessel CUNY1 on Jamaica Bay, and to explore a part of the Hudson Raritan Estuary system.
Poor metabolic health can age the brain even in young people, finds new large-scale study
Two people of very different ages can have a similar level of biological aging in their brains. Such an occurrence is possible because aging and metabolic health follow two distinct pathways that influence ...
Service & Solidarity Spotlight: Health Care Professionals in New Jersey Ratify New Contract
Members of United Food and Commercial Workers (UFCW) Local 152 who work at Cape Regional Physicians Associates (CRPA) in New Jersey have secured a powerful new collective bargaining agreement.
Supreme Court protects pesticides from some health claims in key Roundup case
The Supreme Court on Thursday restricted Americans’ ability to sue pesticide makers over alleged health harms stemming from their products. In a 7-2 ruling, the court held that some claims that pes…
Myles Garrett's Rise Could Fuel T.J. Watt's Next Steelers Surge
For years, T.J. Watt and Myles Garrett have been linked in one of the NFL's defining player rivalries. Now, with Garrett pulling ahead in recent seasons and Patrick Graham arriving in Pittsburgh, Watt has fresh reasons to respond. For much of their careers, Watt's production far outpaced Garrett's. That changed in 2023 when the Cleveland Browns hired Jim Schwartz as defensive coordinator and Garrett elevated his game to another level.
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
Psychedelic Science 2027 (PS27) convenes May 3–7, 2027, at the Colorado Convention Center in Denver under the theme “Bridging Promise & Practice”PS27’s speaker submission is now open through Friday, September 18, with no planned extensionsPS27 welcomes proposals across science, therapy, policy, culture, industry, the humanities, spirituality, connected movements, and the wisdom traditions that have carried this work for generations DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary
Can your smartwatch detect sleep apnea?
No smartwatch can actually diagnose sleep apnea, but some can track certain signs that might indicate you have the condition.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
The Pick Is In: Hallmark Media, NFL and Skydance Sports partner with the Chicago Bears for Holiday Touchdown: A Bears Love Story set to premiere during Hallmark Channel’s 17th annual Countdown to Christmas programming event
Hallmark Media, NFL and Skydance Sports on Thursday announced that the Chicago Bears have been drafted for Holiday Touchdown: A Bears Love Story, the third all-new original movie in the successful franchise, set to premiere later in 2026 during Hallmark C
These Seattle bar and cafe owners are bringing fresh energy to the Ave
From the new owner of the beloved College Inn Pub to a new wave of cafes and teahouses, these University District business owners are reinvesting in the Ave.
UPS is losing ground to FedEx
The two logistics giants have similar strategies—and face a common threat
Lionel Richie cuts concert short over health issue after sitting down mid-performance
"What I have learned about my years of being in the business. When you are feeling dizzy, sit your ass down," Richie told the crowd.
🇺🇸 Y! Sports AM: Why not U.S.?
The USMNT, who play their final group stage match tonight, have given fans reason to believe in their status as contenders.
Europe's heatwave shifts east as as France raises health alert to highest level
Temperatures in Germany could hit 40C in some areas while French officials say deaths linked to the heat are being seen among young people.
Dolly Parton Makes Surprise Appearance Following Health Issues
Dolly Parton made a surprise appearance at the grand opening of her travel stop in Tennessee just one month after she canceled an upcoming Vegas residency due to health concerns.
Brownsville shuts down seven businesses in city's entertainment district over code violations
Seven late-night businesses along Brownsville's Pablo Kisel Boulevard entertainment district have been ordered to close after the city revoked their certificates of occupancy for code and safety ordinance violations.
LA's political coalitions have been shifting. Nithya Raman will shuffle them even more
As Mayor Karen Bass and challenger Nithya Raman look to attract new supporters, a fault line between older and newer Angelenos could emerge.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Ball State Teacher Preparation Programs Earn Top Ratings in Science of Reading Reviews
Ball State University’s elementary education, early childhood education, and special education teacher preparation programs have earned top marks in two reviews focused on how well future educators are prepared to teach reading through evidence-based, scientifically grounded instruction.
Highest June minimum temperature record broken in Cardiff as ‘savage’ heatwave continues
Thermometer only drops to 23.5C overnight in Welsh capital as climate crisis makes such extreme temperatures more severe and more likely
How did Austin Reaves beat odds, land $185M deal with Lakers? Tiny town knows
A teacher, a coach and friend from Austin Reaves' hometown of Newark, Arkansas share insight into his success on way to a $185M deal with the Lakers.
Rochester Business Hall of Fame announces Class of 2026
Junior Achievement of Central Upstate New York and the Rochester Business Journal announced that three business leaders will be inducted into the Rochester Business Hall of Fame in 2026, joining 155 others who previously have been honored for their contributions to Rochester.
Looking Back on Notre Dame’s Rout of Texas in 1995
Further proof that the Texas Longhorns don’t do so well when they travel to South Bend.
Supporters of KY’s Lee Specialty Clinic supporters want politics put aside to avert cuts
Over 100 people rallied in support of Lee Specialty Clinic in Frankfort Wednesday afternoon and testified on the importance of its services.
World Cup: can big sports events bring us together? Recent history says yes
Although fleeting, sporting events have the enduring power to crumble divisions and highlight the beauty of kinship
Commentary: Why Archie Bunker voters are disillusioned with U.S. politics
The 1970s “All in the Family” stalwart supported law-and-order, cultural conservatism and strong labor unions, values to which many Republicans have gravitated, while Democrats evolved into a constituency that adopted identity…
Bacteria-killing viruses redirect vaccine immunity to destroy cancer
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from vaccines
Fermented Food: Does Eating Kimchi or Sauerkraut Have Health Benefits?
Researchers are starting to understand how foods like kimchi, yogurt and sauerkraut affect our health.
Ted Cruz’s not-so-secret White House dreams have gotten JD Vance’s attention and annoyed Trump allies
An ice cream social at a supporter’s house. A meet-and-greet with veterans. A roundtable with sheriffs. An evening rally at a sweltering barbecue joint and a winding photo line afterward.
Jeffrey Epstein's friends' settlements draw Congress' interest
Members of Congress have discussed issuing subpoenas to find out about the NDAs between some of Jeffrey Epstein's friends and his accusers.
Best Prime Day laptop deals: Save up to $970 on MacBooks, Windows PCs
Laptops are very expensive these days. These discounts help.
Union issues spark conflict between Group Health Co-op and members
Changes in the Group Health bylaws have become a point of contention for members who say they are ignored by the co-op's management,
Scientists have just unlocked the secrets of an ancient scroll torched by Mount Vesuvius
After a centuries-long struggle, scholars managed to read five feet of text, using machine-learning methods they hope can unlock further discoveries.
Chemours looks to settle federal PFAS case for $450 million. NC wasn’t at the table.
North Carolina is home to the only Chemours facility GenX facility, yet the state may have no claim to any of the PFAS penalty funds.
A lack of funding, a glut of stigma: How Ohio LGBTQ+ health outcomes are impacted
For the 1 in 10 Ohioans who identify as LGBTQ+, media representation and social acceptance may have improved, but stigma and discrimination still impact them in large aspects of their lives, including healthcare access.
19 fours, 6 sixes! Vaibhav Sooryavanshi's younger brother Ashirvad Sooryavanshi hits blistering century
Young cricketer Ashirvad Sooryavanshi, just 10 years old, is making waves with his exceptional batting. He recently smashed a stunning 168 off 119 balls in a practice match, following a debut century. Despite only six months of playing, his aggressive style and big scores are drawing attention, even from his brother Vaibhav, who is currently with the Indian team.
Griffin Jax Leads Rays Past Royals 5-3 as Tampa Bay Snaps Two-Game Skid
The Rays snapped their two-game skid with a 5-3 win over the Royals as Griffin Jax continued to shine in the rotation. Tampa Bay also got key contributions from Jonathan Aranda, Yandy Díaz, and Jonny DeLuca, while Bryan Baker locked down his 20th save of the season.
We finally have an opening date for the California Science Center’s space shuttle–centric expansion
Space Shuttle Endeavour is in place, and the Samuel Oschin Air and Space Center is (almost) ready for takeoff.
NFL insider thinks Commanders have some questions about Brandon Aiyuk
Washington Commanders: Don't pencil in Brandon Aiyuk to DC yet says Adam Schefter.
Whitchurch firms notice drop in business due to heatwave
Businesses say people are staying at home or relaxing rather than shopping.
Is The G.O.A.T Debate Over?
Another Messi Masterclass leaves us wondering, is the GOAT debate settled for good? Master & Will debate it, and they launch an all-sport GOAT draft, All that being said about Lionel... could Kylian Mbappé catch the goal record as soon as this World Cup? We're joined by North-East football royalty, Argentine Julio Arca, and French football savant Erik Bielderman.
Here's where you can stream “Gilmore Girls” once it leaves Netflix after 12 years
Netflix previously revived the beloved drama with a miniseries.
CMS projection: 90% of Americans will still have health insurance in 2034—when healthcare spending reaches $9T
Legislative changes, demographic shifts and growing demand will combine to drive national health spending to almost $9 trillion by 2034.
Travis Kelce's Journey: From Rookie to NFL Superstar and His Life with Taylor Swift
Travis Kelce is entering his 14th season in the NFL, all of which have been with the Kansas City Chiefs. After being selected No. 63 overall in the third round of the 2013 NFL Draft by Kansas City, Kelce played only a single special teams snap as a rookie, in a Week 2 game against the Dallas Cowboys. The seven-time All-Pro has set all-time marks for the Chiefs, such as surpassing Hall of Fame tight end Tony Gonzalez's 10,940 career receiving yards (13,002) and passing three-time first-team All-Pro Priest Holmes' 83 total career touchdowns (85).